本文選題：肝細胞癌 + 預后��； 參考：《廣西醫(yī)科大學》2017年碩士論文

【摘要】：目的:探究影響HCC患者行肝部分切除術后遠期生存的因素,以期能為HCC患者的臨床治療及預后評估提供理論依據。方法:回顧性分析237例術后生存時間超過5年HCC患者的臨床及隨訪資料,選擇可能影響患者預后的因素,包括:性別、年齡、腫瘤數目、腫瘤大小、BCLC、肝功能Child-pugh分級、ALT、AST、TBIL、GGT、ALB、AFP、圍手術期輸血、腫瘤是否復發(fā)及復發(fā)后治療等變量。采用SPSS 22.0軟件進行計算分析,Kaplan-Meier法計算患者的無瘤生存率及總體生存率,Log-rank檢驗進行單因素分析,多危險因素采用COX模型分析,篩選出影響HCC術后生存時間較長患者復發(fā)及遠期生存的獨立預后因素。結果:單因素分析提示腫瘤數目、BCLC、圍手術期輸血是術后生存期較長患者腫瘤復發(fā)的危險因素,差異有統(tǒng)計學意義(P0.05)。多因素分析提示腫瘤數目及圍手術期輸血是術后生存時間較長患者腫瘤復發(fā)的獨立影響因素。單因素分析顯示:性別、年齡、腫瘤數目、BCLC、圍手術期輸血、腫瘤復發(fā)后治療方式與術后生存時間較長患者的預后相關,差異有統(tǒng)計學意義(P0.05)。所有被納入本研究的患者中,有101例(42.6%)發(fā)生腫瘤復發(fā),根據患者復發(fā)后不同的治療方式納入Log-rank檢驗,再次接受手術治療患者的中位生存時間顯著長于非手術患者(P0.05)。COX多因素回歸分析顯示:年齡、腫瘤數目、圍手術期輸血是HCC術后生存時間較長患者預后的獨立影響因素,差異有統(tǒng)計學意義(P0.05)。結論:1、對于術后生存時間較長的HCC患者,性別、年齡、腫瘤數目、BCLC、圍手術期是否輸血以及腫瘤復發(fā)后治療方式有關,其中年齡、腫瘤數目、圍手術期輸血是其遠期生存的獨立影響因素。2、術后生存時間超過5年的HCC患者復發(fā)后再次手術治療效果顯著好于非手術治療。
[Abstract]:Objective: to explore the factors influencing the long-term survival of HCC patients after partial hepatectomy, and to provide theoretical basis for the clinical treatment and prognosis evaluation of HCC patients. Methods: the clinical and follow-up data of 237 patients with HCC whose survival time was more than 5 years after operation were analyzed retrospectively. The factors that might influence the prognosis of HCC patients were selected, including sex, age, tumor number. BCLC, Child-pugh grade of liver function, liver function and liver function. SPSS22.0 software was used to calculate the tumor-free survival rate and overall survival rate of patients by Kaplan-Meier method. The single factor analysis was performed by Log-rank test, and the multiple risk factors were analyzed by Cox model. The independent prognostic factors affecting the recurrence and long-term survival of HCC patients were screened. Results: univariate analysis showed that tumor number and perioperative blood transfusion were the risk factors of tumor recurrence in patients with long survival period (P0.05). Multivariate analysis suggested that tumor number and perioperative blood transfusion were independent factors of tumor recurrence in patients with long postoperative survival time. Univariate analysis showed that sex, age, tumor number and BCLC, perioperative blood transfusion, treatment methods after tumor recurrence and the prognosis of patients with longer survival time were significantly different (P0.05). Of all the patients enrolled in the study, 101 (42.6%) developed tumor recurrence, which was included in the Log-rank test according to the different treatment methods after recurrence. The median survival time of patients undergoing reoperation was significantly longer than that of non-operative patients (P0.05) .Cox multivariate regression analysis showed that age, tumor number and blood transfusion in perioperative period were independent factors influencing the prognosis of patients with HCC. The difference was statistically significant (P0.05). Conclusion: the sex, age, tumor number, blood transfusion during perioperative period and the treatment method after tumor recurrence are related to the survival time of HCC patients, age and tumor number. Perioperative blood transfusion was the independent factor of long-term survival. The recurrence of HCC patients with survival time of more than 5 years after operation was significantly better than that of non-operative treatment.
【學位授予單位】：廣西醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2017
【分類號】：R735.7

【參考文獻】

相關期刊論文 前10條

1 梁雪婧;李智賢;梁水庭;;原發(fā)性肝癌術后生存10年以上94例分析[J];重慶醫(yī)學;2017年08期

2 楊婉婷;侯恩存;;原發(fā)性肝癌治療的研究進展[J];現代腫瘤醫(yī)學;2016年21期

3 戴穎;孫楊安;;糖尿病對肝硬化患者并發(fā)原發(fā)性肝癌的影響[J];中國現代醫(yī)生;2016年21期

4 Hong-Ling Feng;Qian Li;Lin Wang;Gui-Yu Yuan;Wu-Kui Cao;;Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure[J];Hepatobiliary & Pancreatic Diseases International;2014年03期

5 劉森;;肝癌的預后及長期生存影響因素的研究進展[J];遼寧醫(yī)學院學報;2014年02期

6 楊為中;芮景;;圍手術期輸血對原發(fā)性肝細胞癌術后早期復發(fā)影響的Meta分析[J];山東醫(yī)藥;2013年12期

7 陳實;王耀東;;復發(fā)性肝癌的治療[J];中華普通外科學文獻(電子版);2012年05期

8 周建平;周偉平;;可切除大肝癌術前TACE對手術的影響[J];臨床軍醫(yī)雜志;2012年04期

9 雷正明;付文廣;鄭振江;葉明新;黎靖;;巨大肝癌外科治療探討[J];中國普通外科雜志;2012年01期

10 樊嘉;王征;;肝癌外科治療的進展[J];實用醫(yī)院臨床雜志;2011年01期

，

本文編號：2079049